Wortmannin inhibits translation of tumor necrosis factor-α in superantigen-activated T cells

International Immunology

Volumn 11, Issue 9, 1999, Pages 1479-1489

  Ramirez, Matilde ^a   Fernández Troy, Neus ^a   Buxadé, Maria ^a   Casaroll Marano, Ricardo P ^a   Benítez, Daniel ^b   Pérez Maldonado, Cesar ^a   Espel, Enric ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

LY 294002; p38 mitogen activated protein kinase; Phosphatidylinositol 3 kinase; SB 203580; Toxic shock syndrome toxin 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD4 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSLATION REGULATION;

EID: 0344549847     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.9.1479     Document Type: Article

References (39)

1. Vasali, P. (1992). The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
2. Han J., Brown, T. and Beutler, B. 1990. Endotoxin-responsive sequences control cachetin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465.
3. Espel, E., García-Sanz, J. A., Aubert, V., Menoud, V., Sperisen, P., Fernández, N. and Spertini, F. 1996. Transcriptional and translational control of TNF-α gene expression in human monocytes by major histocompatibiliy complex class II ligands. Eur. J. Immunol. 26:2417.
4. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W., Strickler, J. E., McLaughlin, M. M., Siemens, I. R., Fisher, S. M., White, J. R., Adams, J. L., Young, P. R. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
5. Fukunaga, R. and Hunter, Y. 1997. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1921.
6. Waskiewicz, A. J., Flynn, A., Proud, C. G. and Cooper, J. A. 1997. MAPKs activate the ser/thre kinases Mnk1 and Mnk2. EMBO J. 16:1909.
7. Waskiewicz, A. J., J. J. C., Penn, B., Mahalingham, M., Kimball, S. R., and Cooper, J. A. 1999. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mk1 in vivo. Mol. Cell. Biol. 19:1871.
8. Pyronnet, S. I. H., Gingras, A. C., Fukunaga, R., Hunter, T. and Sonenberg, N. 1999. Human eukaryotic translation initiation factor 4F (elF4G) recruits Mnk1 to phosphorylate elF4E. EMBO J. 18:270.
9. Guy-Grand, D., DiSanto, J. P., Henchoz, P., Malassis-Seris, M. and Vassalli, P. 1998. Small bowel epithelial cell death and renewal. Eur. J. Immunol. 28:730.
10. Feldmann, M., Brennan, F. M., and Maini, R. N. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
11. Boal, T. R., Chiorini, J. A., Cohen, R. B., Miyamoto, S., Frederickson, R. M., Sonenberg, N. and Safer, B. 1993. Regulation of eukaryotic translation initiaton factor during T-cell activation. Biochim. Biophys. Acta. 1176-257.
12. Jedlicka, P., and Panniers, R. 1991. Mechanism of activation of protein synthesis initiation in mitogen-stimulated T lymphocytes. J. Biol. Chem. 266:15663.
13. Welsh, G. I., Miyamoto, S., Price, N. T., Safer, B., and Proud, C. G. 1996. T-cell activation leads to rapid stimulation of translation initiation factor elF2B and invativation of glycogen synthase kinase-3. J. Biol. Chem. 271:11410.
14. Garcia-Sanz, J. A., Milkulits, W., Livingstone, A., Lekkovits, I. and Nüllner, E. W. 1988. Translational control: a general mechanism for gene regulation during T cell activation. FASEB J. 12:299.
15. Monfar, M., Lmon, K. P., Grammer, T. C., Cheatham, L., Chung, J., Vlahos, C. J. and Blenis, J. 1995. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15:326.
16. Reif, K., Burgering, B. M. T., and Cantrell, D. A. 1997. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272:14426.
17. Parry, R. V., Reif, K., Smith, G., Sansom, D. M., Hemmings, B. A. and Ward, S. 1997. Ligation of the T cell co-stimulatory receptor Cd28 activates the serine-threonin protein kinase protein kinase B. Eur. J. Immunol. 27:2495.
18. S6k. EMBO J. 16:3693.
19. Gingras, A.-C., Kennedy, S. G., O'Leary, M. A., Sonenberg, N. and Hay, N. 1998. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12:502.
20. Arcaro, A. and Wymann, M. P. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol, 3,4,5-triphosphate in neutrophil responses. Biochem. J. 296:297.
21. Yano, H., Nakashini, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y. and Matsuda, Y. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.
22. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F. 1994. A specific inhibitor of phosphatidylinositol 3-kinase,2(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
23. Ward, S. G., Wilson, A., Turner, L., Westwick, J. and Sanson, D. M. 1995. Inhibition of CD28-mediated T cell costimulation by the phosphoinosotide 3-kinase inhibitor wormannin. Eur. J. Immunol. 25:526.
24. Ueda, Y., Levine, B. L. Huang, M. L., Freeman, G. J., Nadler, L. M., June, C. H. and Ward S. G. 1995. Both CD28 ligands Cd80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogenety in the regulation of T cell IL-2 secretion. Int. Immunol. 7:957.
25. Ghiotto-Ragueneaus, M., Battifora, M., Truneh, A., Waterfield, M. D. and Olive, D. 1996. Comparison of Cd28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur. J. Immunol. 26:34.
26. Chomczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guianidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
27. Ward, S. G., June, C. H. and Olive, D. 1996. Pl 3-kinase: a pivotal pathway in T-cell activation? Immunol. Today 17:187.
28. Spertini, F., Spits, H. and Geha, R. S. 1991. Staphyloccocal exotoxins deliver activation signal to human T-cell clones via major histocompatibility complex class I molecules. Proc. Natl Acad Sci. USA 88:7533.
29. s6k by PDK1. Science 297:707.
30. Brunn, G. J., Hudson, C. C., Sekulic, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., Jr and Abraham, R. T. 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99.
31. Beretta, L., Gingras, A. C., Svitkin, Y. V., Hall, M. N., Stonenberg, N. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658.
32. Pearson, R. B., Dennin, P. B., Han, J.-W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E. H. and Thomas, G. 1995. The principal target of rapamycin-induced p70S6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain, EMBO J. 14:5279.
33. Pullen, N., and Thomas, G. 1997. The modular phosphorylation and activation of p70s6k. FEBS Lett. 410:78.
34. Cuenda, A., Cohen, P., Burée-Scherrer, V. and Goedert, M. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) EMBO J. 16:295.
35. Jefferies, H. B. J., and Thomas, G. 1996. Ribosomal protein S6 phosphorylation and signal transduction. In Hershey, J. W. B., Mathews, M. B. and Sonenberg, N., eds. Translational Control, p. 389. Cold Spring Habor Laboratory Press, Cold Spring Harborn, NY.
36. Karnitz, L. M., Burns, L. A., Sutor, S. L., Blenis, J. and Abraham, R. T. 1995. Interleukin-2 triggers a novel phosphatidlyinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15:3049.
37. Sutor, S. L., Vroman, B. T., Armstrong., E. A., Abraham, R. T. and Karnitz, L. M. 1999. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-raf and A-raf. J. Biol. Chem. 274:7002.
38. Geppert, T. D., Whitehurst, C. E., Thompson, P. and Beutler, B. 1994. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1-MEK/MAPK pathway. Mol. Med. 1:93.
39. Swanek, J. L., Cobb, M. H. and Geppert, T. D. 1997. Jun-N-terminal kinase/Stress-activated protein kinase (JNK/SAPK) is required for lipolpolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocortocoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17:6274.